Welcome to Suturion – a pioneer in abdominal wall closure and medical technology.
Suturion was founded in 2018 by Dr. Gabriel Börner on the idea of developing innovation to enable surgeons to follow the guidelines of the small-bites technique when performing an abdominal wall fascia closure. Recognizing a significant clinical need in this area, we developed SutureTOOL, a groundbreaking medical device designed to help surgeons to perform a standardized, efficient and safe fascia closure.
Our vision is to redefine excellence in abdominal wall closure by setting newglobal standards for safety, efficiency, and cost-effectiveness. Therefore, we strive to develop and commercialize groundbreaking technology to support surgeons, nurses and patients for improved patient outcomes.
We always prioritize our customers and uphold our ethical standards.
By positioning Suturion as an innovative global partner, we aim for sustainable growth and value for our shareholders.
We foster a culture of competence and entrepreneurship, supporting personal and professional growth as part of our company philosophy.
Our shareholders are key to realizing our long-term goals, and we ensure transparency and value their expertise.
With a strong Swedish foundation and a global outlook, we are committed to setting new standards in abdominal wall closure. Together, we can shape the future of healthcare and improve patients’ lives worldwide.
Thank you for your trust and support.
Best regards,
Paan Hermansson
CEO, Suturion
Vision and Mission
Our Mission
To revolutionize abdominal wall closure by providing innovative solutions that improve patient outcome, secure surgical precision and reduce healthcare costs.
Our Vision
To redefine excellence in abdominal wall closure, setting new global standards for safety, efficiency, and cost-effectiveness.
Company Values
Build Excellence
We consistently build excellence by improving our knowledge and skills, our team interactions, and our unwavering commitment to excel in customer interactions.
Be Bold
We aspire to set new and ambitious benchmarks and challenge conventional standards through a science-based approach and an entrepreneurial mindset.
Sustain Dedication
We pursue sustainable and respectful decision-making, and are firmly dedicated to our patients, surgeons, nurses and employees.
From a surgeon’s curiosity
to an innovative solution
It started with a curious surgeon on a quest to solve a clinical problem. Dr Gabriel Börner, during his training and practice, often saw patients suffer from complications after open abdominal surgery. Inspired by new evidence that a refined suturing technique could reduce these complications, he envisioned a better way.
Teaming up with MedTech engineer Mats O. Christensson and LU Holding AB, Gabriel founded Suturion AB in 2018. Their mission: to create an easy-to-use suturing device for standardized and consistent high-quality closure of the abdominal wall in a fast and safe way. This vision became SutureTOOL, a groundbreaking medical device designed to help surgeons adopt the small-bites technique with precision and efficiency.
Through extensive pre-clinical research and several patents, Suturion reached an important milestone in 2024 by completing a clinical trial, paving the way for CE and FDA approval. What began as a simple idea is now set to transform surgical care and improve patient outcomes worldwide.
Suturion Milestones
LUIS, Lund University Innovation System collaboration
1st preclinical study
Suturion® founded
Suturion® brand name protected in EU and US
Patents granted in EU (6 areas)
SutureTOOL™ design established
CEO employed
Swedish MedTech member
SMiLe collaboration
European Hernia Society Partnership
Establishment of Medical Advisory board EU
Patents granted in US (3 areas)
Distribution Agreement HC21, UK
Distribution Agreement Sarabeel, Saudi Arabia
Clinical trial completed
SutureTOOL trademark
10 employees
Patent granted in Japan
Distribution agreement Optimed Technologies, Australia
Establishment of Medical Advisory board US
FDA clearance
ISO 13485 certified
CE marking (MDR)
Publication of clinical trial
SutureTOOL™ global launch summit
LUIS, Lund University Innovation System collaboration
1st preclinical study
Suturion® founded
Suturion® brand name protected in EU and US
Patents granted in EU (6 areas)
SutureTOOL™ design established
CEO employed
Swedish MedTech member
SMiLe collaboration
European Hernia Society Partnership
Establishment of Medical Advisory board EU
Patents granted in US (3 areas)
Distribution Agreement HC21, UK
Distribution Agreement Sarabeel, Saudi Arabia
Clinical trial completed
SutureTOOL trademark
10 employees
Patent granted in Japan
Distribution agreement Optimed Technologies, Australia
Establishment of Medical Advisory board US
FDA clearance
ISO 13485 certified
CE marking (MDR)
Publication of clinical trial
SutureTOOL™ global launch summit
Commitment to Quality
At Suturion, quality is built into everything we do – from product development to patient impact. Our Quality Management System is certified according to ISO 13485 and MDSAP, and our products are FDA cleared and CE marked (MDR). We are committed to meeting the highest regulatory standards while supporting safe, effective surgical care.
Sign up for Suturion newsletter
